Relaño-Rodríguez, I.
Espinar-Buitrago, M. S.
Martín-Cañadilla, V.
Gómez-Ramirez, R.
Jiménez, J. L.
Muñoz-Fernández, M. A. http://orcid.org/0000-0002-0813-4500
Funding for this research was provided by:
Instituto de Salud Carlos III (RD16/0025/0019, PT17/0015/0042, PI16/01863, PI19/01638, CIBER-BBN)
Instituto de Salud Carlos III (PI17/01115)
Comunidad de Madrid (B2017/BMD-3703, PEJ-2018-TL/BMD-11529, PEJD-2019-PRE/IND-16567)
PENTA FOUNDATION (EPIICAL Project)
IISGM (COV20/MAM-BIS)
Uniwersytet Medyczny w Lodzi (NAWA International Academic Partnership Programme)
European Cooperation in Science and Technology (OST Action CA 17140 "Cancer Nanomedicine from the Bench to the Bedside")
Article History
Received: 6 November 2020
Accepted: 18 February 2021
First Online: 3 March 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.